Mucocutaneous leishmaniasis associated with HIV infection treated successfully with liposomal amphotericin B (AmBisome) [12]

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue 2, 2000, Pages 341-342

  Amato, V S ^a   Nicodemo, A C ^a   Amato, J G ^a   Boulos, M ^a   Neto, A ^a  

^a Clinical Hospital   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CD4 ANTIGEN; CD8 ANTIGEN; MEGLUMINE ANTIMONATE; PENTAMIDINE ISETHIONATE; VIRUS RNA;

ADULT; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LEISHMANIA BRAZILIENSIS; LETTER; MALE; MOUTH LESION; PENIS DISEASE; SKIN LEISHMANIASIS; TREATMENT OUTCOME;

ADULT; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; HIV INFECTIONS; HUMANS; LEISHMANIASIS, MUCOCUTANEOUS; MALE;

EID: 0033887406     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Mucosal leishmaniasis ('espundia' Escomel, 1911)
2. Pentavalent antimonial therapy in mucosal leishmaniasis
3. Human leishmaniasis: Clinical, diagnostic and chemotherapeutic developments in the last 10 years
4. Traitement par isethionate de pentamidine de la leishmaniose muqueuse
5. American cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis as an initial clinical presentation of human immunodeficiency virus infection
6. Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome